Abiopharma

🔍 KANE CHARLES (Director)

Company: Symbotic Inc. (SYM)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Sold 2,000 shares of Class V-1 Common Stock (Direct)
  Date: 2026-05-01 | Code: J | equity_swap_involved: 0 | shares_owned_after: 591,353.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Acquired 2,000 shares of Class A Common Stock (Direct)
  Date: 2026-05-01 | Code: J | equity_swap_involved: 0 | shares_owned_after: 91,852.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 300 shares of Class A Common Stock at $56.9007 per share (Direct)
  Date: 2026-05-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 91,552.00 | transaction_form_type: 4 | Footnotes: F4, F5
• Sold 1,252 shares of Class A Common Stock at $58.2654 per share (Direct)
  Date: 2026-05-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 90,300.00 | transaction_form_type: 4 | Footnotes: F4, F6
• Sold 448 shares of Class A Common Stock at $59.1667 per share (Direct)
  Date: 2026-05-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 89,852.00 | transaction_form_type: 4 | Footnotes: F4, F7
• Sold 2,000 shares of Symbotic Holdings Units (Derivative)
  Date: 2026-05-01 | Code: J | equity_swap_involved: 0 | shares_owned_after: 591,353.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F1, F1

Footnotes:

• F1: Shares of Class V-1 Common Stock of the Issuer have no economic rights and each share of Class V-1 Common Stock entitles its holder to 1 vote per share.
• F2: The term "Symbotic Holdings Units" is used herein to represent limited liability company units of Symbotic Holdings LLC ("Symbotic Holdings") and an equal number of paired shares of Class V-1 Common Stock of the Issuer, which, pursuant to the limited liability company agreement of Symbotic Holdings, are redeemable by the holder on a one-for-one basis for a share of Class A Common Stock of the Issuer, subject to conversion rate adjustments for stock splits, stock dividends, reclassification and other similar transactions, and in accordance with other terms and conditions set forth in Symbotic Holdings' Second Amended and Restated Limited Liability Company Agreement, dated as of June 7, 2022. Upon redemption, the Issuer will cancel the Symbotic Holdings Units and cancel and retire for no consideration the redeemed shares of Class V-1 Common Stock.
• F3: On May 1, 2026, the Reporting Person sold 2,000 shares of Class A Common Stock pursuant to a trading plan entered into by the Reporting Person on December 8, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Stock Sale"). In connection with the Stock Sale and pursuant to the terms of the trading plan, effective May 1, 2026, the Reporting Person redeemed 2,000 Symbotic Holdings Units in exchange for an equal number of shares of Class A Common Stock (the "Redemption"). In connection with the Redemption, Symbotic Holdings canceled the Symbotic Holdings Units, and the Issuer canceled and retired for no consideration the redeemed 2,000 shares of Class V-1 Common Stock.
• F4: This transaction was executed pursuant to a trading plan entered into by the Reporting Person on Decmeber 8, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
• F5: In accordance with SEC guidance authorizing aggregate reporting of same-day purchases and sales, the shares were sold in multiple transactions at prices ranging from $56.52 to $57.09, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F6: In accordance with SEC guidance authorizing aggregate reporting of same-day purchases and sales, the shares were sold in multiple transactions at prices ranging from $57.77 to $58.73, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F7: In accordance with SEC guidance authorizing aggregate reporting of same-day purchases and sales, the shares were sold in multiple transactions at prices ranging from $58.90 to $59.37, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.